Prevalence of genito-urinary symptoms in the late menopause.
about
Oestrogen therapy for urinary incontinence in post-menopausal womenOestrogen therapy for urinary incontinence in post-menopausal womenLocal oestrogen for vaginal atrophy in postmenopausal womenLocal oestrogen for vaginal atrophy in postmenopausal womenVulvovaginal atrophy.Evaluation of the effects of a new intravaginal gel, containing purified bovine colostrum, on vaginal blood flow and vaginal atrophy in ovariectomized rat.Dyspareunia is associated with decreased frequency of intercourse in the menopausal transitionThe effects of hormones on urinary incontinence in postmenopausal women.Systematic review of sexual problems: epidemiology and methodology.Urinary symptoms in breast cancer: a systematic review.Urinary tract infection in postmenopausal women.Local Effects of Vaginally Administered Estrogen Therapy: A Review.Efficacy of Erbium:YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopauseRecurrent Urinary Tract Infections Management in Women: A reviewDyspareunia in postmenopausal women: a critical review.Topical estrogen therapy in the management of postmenopausal vaginal atrophy: an up-to-date overview.Expert Panel Recommendations on Lower Urinary Tract Health of Women Across Their Life Span.Urinary tract infections in postmenopausal women.Does estrogen have any real effect on voiding dysfunction in women?Role of estrogens in the treatment of female urinary incontinence.Non-hormonal topical treatment of vulvovaginal atrophy: an up-to-date overview.Oestrogens and overactive bladder.Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and The North American Menopause Society.Pharmacological treatment of pure stress urinary incontinence: a narrative review.Vaginal oestrogen for overactive bladder in post-menopausal women.Oestrogen replacement in postmenopausal women.The role of local estrogen therapy in the management of pelvic floor disorders.Local oestrogen for vaginal atrophy in postmenopausal women.The comparison of hyaluronic acid vaginal tablets with estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial.Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet.17beta-estradiol induces the proliferation of the in vitro cultured human urothelium.Safety issues associated with using medication to treat overactive bladder.Topographies and isoforms of the progesterone receptor in female human, rat and mouse bladder.Sex hormones, the menopause and urinary problems.Does vaginal estrogen treatment with support pessaries in vaginal prolapse reduce complications?The menopause revisited.Urinary incontinence in Northern Ireland: a prevalence study.Compliance with hormone replacement therapy among Swedish women.Considering the prominent complaint as a guide in medical therapy for overactive bladder syndrome in women over 45 years.Local estrogen treatment in patients with urogenital symptoms.
P2860
Q24198065-BE6C46EF-09C6-4629-BFDE-09321FFC5F95Q24240302-F448A036-FA5C-45C4-84A6-E880D6F15E33Q24244276-C869A887-756D-44EF-A1AD-8EEEACD2D7BCQ24247740-CEA61907-B9DF-4C15-A927-D89F0E43949EQ33566744-27CBA550-BAFA-413F-9DF0-8AE1172C812EQ34286219-92C91D57-16C9-4486-B299-5059D482DC36Q34520701-AE813386-0E58-458D-BF8F-C7F43799208CQ34605075-20F31A7A-1C03-4175-B89D-B235E116879FQ34961873-2FD3762A-AECB-4D7F-8266-E395B88BDBC7Q35354249-B9F6CE25-5C34-43D6-B060-0CF539A2D198Q35635503-1C803453-355D-414F-AA10-923B207B3ECAQ35654573-A8142934-6CB4-4ABF-BF86-27DEA9068F23Q36108656-631B24D5-3AF9-4494-82D6-6912C9681DB7Q37109572-8CCE6028-2576-4D1C-90C0-1BD76772AF3BQ37164377-280A87A3-198A-4590-ACDA-9B7D8CC255F5Q37360543-E7AC68F6-5C95-4046-9414-EB28ED5DE8D8Q37424934-DA2E5D45-DE65-4287-889F-3705C7F80DAEQ37682456-3BF5FC25-6873-4C1D-8D16-85804EE31D0DQ37898043-C1EBCC2C-15B3-4882-8C61-2814837080A4Q37906672-79E2BB89-50DC-404D-B41D-6CE320F53EB0Q38065195-4BEF5BA3-1086-4279-BFE5-1F5150C21A8AQ38122627-28CF7BBD-22CD-4439-BF84-EE34245BBBADQ38242862-E0210F32-F745-44FC-B9AE-3A2428183572Q38335674-DBC2F045-01E1-4591-83A2-3CD55E13ECE6Q38525693-8EAEED5D-D371-4F57-97E1-15C83E733B7EQ38526762-C7E0B906-72BB-4D30-809B-A6E551635A39Q38717871-87214F3E-BBAE-492E-9100-F637C65DF4EDQ38941662-8A00A881-7065-41AE-B37C-2574E03754B0Q39291461-EEE5F272-E74B-4AC0-82B5-90A2B561EA02Q39368721-200D36F8-F631-4AC3-AB7C-CF9FEEF7241BQ39985680-AB496ED2-70B8-4827-8004-EAB2E3114AACQ40058585-44EE8459-1CAA-4197-A383-367608DD39BEQ40229103-3E3E8643-28DC-4B9A-AADC-D92DB0B5CFF3Q40551555-A0416D6D-5C3A-4F0C-99A9-8662665E1F7CQ40922659-10519110-3F34-4DEE-9B64-7DCD3158D96EQ40959293-8FE4545B-D433-4C75-BBC3-8E4BF02AC6A8Q43337954-523CFA6B-15C9-403E-B4C8-7ACE80993255Q43844854-00B978F8-58E3-4495-9B8A-744895543BE6Q44426277-A0476EF3-006B-4288-956E-3F32C356E8D7Q44520856-00799748-016E-4B12-90C5-E404342A116C
P2860
Prevalence of genito-urinary symptoms in the late menopause.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年学术文章
@wuu
1984年学术文章
@zh
1984年学术文章
@zh-cn
1984年学术文章
@zh-hans
1984年学术文章
@zh-my
1984年学术文章
@zh-sg
1984年學術文章
@yue
1984年學術文章
@zh-hant
name
Prevalence of genito-urinary symptoms in the late menopause.
@en
Prevalence of genito-urinary symptoms in the late menopause.
@nl
type
label
Prevalence of genito-urinary symptoms in the late menopause.
@en
Prevalence of genito-urinary symptoms in the late menopause.
@nl
prefLabel
Prevalence of genito-urinary symptoms in the late menopause.
@en
Prevalence of genito-urinary symptoms in the late menopause.
@nl
P1476
Prevalence of genito-urinary symptoms in the late menopause.
@en
P2093
P304
P356
10.3109/00016348409155509
P577
1984-01-01T00:00:00Z